Estimating individualized treatment rules with risk constraint
From MaRDI portal
Publication:6047773
DOI10.1111/biom.13232zbMath1520.62228OpenAlexW3003174719WikidataQ89460961 ScholiaQ89460961MaRDI QIDQ6047773
Publication date: 9 October 2023
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.13232
risk constraintDC programmingpersonalized medicinemulti-category classificationindividualized treatment ruleoutcome weighted learning
Cites Work
- Unnamed Item
- Unnamed Item
- Performance guarantees for individualized treatment rules
- High-dimensional \(A\)-learning for optimal dynamic treatment regimes
- Variations and extension of the convex-concave procedure
- Regularized outcome weighted subgroup identification for differential treatment effects
- Optimal treatment assignment to maximize expected outcome with multiple treatments
- Estimation and evaluation of linear individualized treatment rules to guarantee performance
- Estimating individualized treatment rules for ordinal treatments
- DC Programming and DCA for General DC Programs
- Tree-based methods for individualized treatment regimes
- Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
- Robust Truncated Hinge Loss Support Vector Machines
- A D.C. Optimization Algorithm for Solving the Trust-Region Subproblem
- Estimating Individualized Treatment Rules Using Outcome Weighted Learning
- Optimal Dynamic Treatment Regimes
- Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies
- A Robust Method for Estimating Optimal Treatment Regimes
- Set‐valued dynamic treatment regimes for competing outcomes
- Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity
- Adaptive Q-learning
This page was built for publication: Estimating individualized treatment rules with risk constraint
